At a joint press conference today with the University of Louisville, it was announced that the world's first adult cardiac stem cell trial will take place at Jewish Hospital!
Dr. Roberto Bolli, Jewish Hospital Heart and Lung Institute Distinguished
Chair in Cardiology, is the lead investigator of the world's first phase
one FDA-approved clinical trial using adult cardiac stem cells to treat
heart disease. Working alongside Dr. Mark Slaughter, Division Chief of
Cardiovascular and Thoracic for the University of Louisville, for the first
time, patients with advanced heart disease who are already undergoing
bypass surgery will be recruited for participation in the clinical trial.
The research study will use adult stem cells taken from the patient's own
cardiac tissue to regenerate tissue that has been damaged by a previous
heart attack.
We are all very proud of the work that Dr's Bolli and Slaughter are doing
at Jewish Hospital! Please let them know how much we appreciate them!
2 comments:
This stem cell research is too cool. Jewish Hosp is going to save so many lives.
What a wonderful opportunity for our patients, community and hospital! Much thanks must be given the physicians who diligently strive to change our patients lives with positive outcomes.
Post a Comment